What is the best dose of Almonertinib per day and medication recommendations?

Almonertinib (Almonertinib) is an oral third-generationEGFR-TKI (epidermal growth factor receptor tyrosine kinase inhibitor), mainly used to treat< /span>EGFR mutation-positive non-small cell lung cancer (NSCLC) patients, especially suitable for T790M mutation-positive patients. The drug blocks the proliferation and metastasis of cancer cells by inhibiting the mutant EGFR signaling pathway and improves patient treatment effects.

Ametinib is usually taken orally as a tablet, once a day, and the standard recommended dose is 110mg/day. Taking it once a day can keep the blood concentration stable and ensure the effective action time of the drug in the body. Patients should use it under the guidance of a doctor and should not increase or decrease the dosage at will to avoid a decrease in efficacy or an increase in the risk of adverse reactions.

Ametinib can be taken with or without food, but it is recommended to take it at the same time every day to keep blood levels stable. When taking the medicine, swallow the tablet whole and avoid crushing or chewing the tablet. If the patient misses a dose, he should take it as soon as possible on the same day. However, if it is close to the time of the next dose, the missed dose should be skipped and two tablets should not be taken at one time.

While taking amitinib, patients should regularly monitor blood routine, liver and kidney function and imaging indicators, and promptly evaluate the efficacy and side effects, such as rash, diarrhea or abnormal liver function, etc. If severe discomfort occurs, you should contact your doctor promptly for dose adjustment or treatment. Following the daily fixed dosage and medication recommendations is an important guarantee to ensure the stable therapeutic effect of Ametinib and reduce adverse reactions.

Reference link:https://www.drugs.com